Supriya Jain, MD
Radiation Oncology · Fort Collins, CONPI 1639597529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Elekta, Inc. at 29.1% of the total. 2024 is the largest year on record at $216, 5.6 times the $39 reported in 2019.
Across 19 payments — averaging $39.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$216
- Siemens Medical Solutions USA, Inc.$171
- Amgen$59
- Viewray Technologies Inc$44
- Daiichi Sankyo Inc.$38
- Johnson & Johnson$35
- plus $181 from 8 others
Across 3 payments — averaging $10,359 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure GmbH$31K
What the payments were for
- Food & beverage$744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 1 | $216 |
| Siemens Medical Solutions USA, Inc. | 1 | $171 |
| Amgen | 3 | $59 |
| Viewray Technologies Inc | 1 | $44 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Johnson & Johnson(2 entities) | 2 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Clovis Oncology, Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Blue Earth Diagnostics | 1 | $18 |
| Incyte Corporation | 1 | $17 |
| Seagen Inc. | 1 | $16 |
How this compares
$744 in reported general payments places this provider in the 60th percentile of 105 radiation oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Fort Collins
- Matthew JacksonFort Collins$2K
- Peter RossiGlenwood Springs$146K
- Suraj SinghGreely$134K
- Meera PatelAurora$112K
- David RabenAurora$61K
- Dustin BootheGreeley$55K
- Kevin ScheweThornton$51K
- Christine FisherAurora$28K
- Thomas PughDenver$15K
- Karyn GoodmanAurora$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.